search
Back to results

Spontaneous Breathing Trial With T-piece or Inspiratory Pressure Augmentation (SBT-TIP)

Primary Purpose

Ventilator Weaning

Status
Recruiting
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
Spontaneous breathing trial (SBT) crossover sequence 1
Spontaneous breathing trial (SBT) crossover sequence 2
Sponsored by
National Taiwan University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Ventilator Weaning focused on measuring Clinical trial, Mechanical ventilation, Respiratory failure, Spontaneous breathing trial, Weaning

Eligibility Criteria

20 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Admitted to the adult intensive care unit (ICU)
  2. Receiving invasive mechanical ventilation via an endotracheal tube
  3. Ready to start an SBT* *The criteria of readiness to an SBT include FiO2 ≤ 0.4, PEEP ≤ 8 cmH2O, minute ventilation ≤ 0.15 L/min/predicted body weight, inspiratory pressure or driving pressure ≤ 14 cm H2O, stable cardiovascular status and no worsening of non-pulmonary organ function.

Exclusion Criteria:

  1. Age < 20 years
  2. Receiving mechanical ventilation via tracheostomy
  3. Mechanical ventilation < 12 hours
  4. Invasive ventilation started before the index hospitalization
  5. On do-not-intubate order

Sites / Locations

  • National Taiwan University HospitalRecruiting
  • National Taiwan University Hospital Hsin-Chu BranchRecruiting
  • National Taiwan University Hospital Yunlin BranchRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Crossover sequence 1

Crossover sequence 2

Arm Description

Cluster-randomization crossover sequence 1: T-piece during odd-numbered months and inspiratory pressure augmentation during even-numbered months.

Cluster-randomization crossover sequence 2: T-piece during even-numbered months and inspiratory pressure augmentation during odd-numbered months.

Outcomes

Primary Outcome Measures

Successful liberation from invasive mechanical ventilation
The primary study endpoint is to compare the effect of SBT with T-piece versus inspiratory pressure augmentation on the proportion of patients with successful liberation from invasive mechanical ventilation in the ICU among patients who have started an SBT. Successful liberation is defined as sustaining iMV free for at least five days after extubation.

Secondary Outcome Measures

Successful liberation from invasive and noninvasive mechanical ventilation
Proportion of successful liberation from invasive and noninvasive mechanical ventilation in the ICU.
Successful liberation from invasive mechanical ventilation
Proportion of successful liberation from invasive mechanical ventilation on day 28 from intubation.
Time to successful liberation from invasive mechanical ventilation
Time to successful liberation from invasive mechanical ventilation using competing-risks analysis.
Time to successful liberation from invasive and noninvasive mechanical ventilation
Time to successful liberation from invasive and noninvasive mechanical ventilation using competing-risks analysis.
Intubation free days
The number of days that a patient is alive and free from intubation.
Adjusted risk ratio of successful liberation from invasive mechanical ventilation
Adjusted risk ratio of successful liberation from invasive mechanical ventilation for T-piece versus inspiratory pressure augmentation group.
Initial SBT success
Proportion of initial SBT success among patients who have started an SBT.
Extubation failure
Proportion of extubation failure among patients undergoing planned extubation.
Proportion of planned extubation
Proportion of planned extubation in the ICU
Use of noninvasive ventilation after extubation
Proportion of use of noninvasive ventilation (>24 hours) after extubation.
ICU mortality
Proportion of death in the ICU.
28-day mortality
Probability of death in 28 days using kaplan-meier estimator.

Full Information

First Posted
December 8, 2019
Last Updated
August 8, 2023
Sponsor
National Taiwan University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04222205
Brief Title
Spontaneous Breathing Trial With T-piece or Inspiratory Pressure Augmentation
Acronym
SBT-TIP
Official Title
A Cluster-Randomized Crossover Trial to Compare Spontaneous Breathing Trial With T-piece or Inspiratory Pressure Augmentation
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 1, 2019 (Actual)
Primary Completion Date
November 30, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
National Taiwan University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Weaning is an important process to gradually separate mechanically ventilated patients from ventilators. A good weaning strategy aims to early identify mechanically ventilated patients who are ready for extubation but not to prematurely extubate them. Spontaneous breathing trial (SBT) is a test to assess the patient's ability to breathe spontaneously when extubated. Several methods have been used to conduct an SBT, including T-piece breathing, low-level pressure support ventilation (PSV) of 5-7 cm H2O, continuous positive airway pressure and automatic tube compensation (ATC). The investigators hypothesized that an SBT with inspiratory pressure augmentation increases initial SBT success, reduces the length of invasive mechanical ventilation (iMV) support and does not increase reintubation risk as compared with T-piece, which result in a higher proportion of patients successfully liberated from iMV in the inspiratory pressure augmentation group. However, inspiratory pressure augmentation significantly reduces work of breathing on an SBT as compared with T-piece. Patients extubated following an SBT with inspiratory pressure augmentation may experience increased respiratory effort after extubation and this may increase the use of noninvasive ventilation after extubation. An SBT with inspiratory pressure augmentation increases iMV free days but not MV free days as compared with T-piece. Longer iMV free days may be associated with a lower mortality due to fewer iMV related complication. This study is a pragmatic, cluster-randomized, multiple crossover, multicenter trial to compare SBTs with T-piece versus inspiratory pressure augmentation in weaning outcomes. Mechanically ventilated patients who meet the criteria for readiness to SBT will be included. The patients will use either T-piece or inspiratory pressure augmentation as SBT for weaning according to an ICU-based cluster randomization and crossover sequence.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ventilator Weaning
Keywords
Clinical trial, Mechanical ventilation, Respiratory failure, Spontaneous breathing trial, Weaning

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Cluster-Randomized Crossover Trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
2143 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Crossover sequence 1
Arm Type
Active Comparator
Arm Description
Cluster-randomization crossover sequence 1: T-piece during odd-numbered months and inspiratory pressure augmentation during even-numbered months.
Arm Title
Crossover sequence 2
Arm Type
Experimental
Arm Description
Cluster-randomization crossover sequence 2: T-piece during even-numbered months and inspiratory pressure augmentation during odd-numbered months.
Intervention Type
Diagnostic Test
Intervention Name(s)
Spontaneous breathing trial (SBT) crossover sequence 1
Intervention Description
SBTs with T-piece breathing for one hour during odd-numbered months and SBTs with inspiratory pressure augmentation for one hour during even-numbered months.
Intervention Type
Diagnostic Test
Intervention Name(s)
Spontaneous breathing trial (SBT) crossover sequence 2
Intervention Description
SBTs with inspiratory pressure augmentation for one hour during odd-numbered months and SBTs with T-piece breathing for one hour during even-numbered months.
Primary Outcome Measure Information:
Title
Successful liberation from invasive mechanical ventilation
Description
The primary study endpoint is to compare the effect of SBT with T-piece versus inspiratory pressure augmentation on the proportion of patients with successful liberation from invasive mechanical ventilation in the ICU among patients who have started an SBT. Successful liberation is defined as sustaining iMV free for at least five days after extubation.
Time Frame
ICU discharge, up to 28 days after the initial SBT
Secondary Outcome Measure Information:
Title
Successful liberation from invasive and noninvasive mechanical ventilation
Description
Proportion of successful liberation from invasive and noninvasive mechanical ventilation in the ICU.
Time Frame
ICU discharge, up to 28 days after the initial SBT
Title
Successful liberation from invasive mechanical ventilation
Description
Proportion of successful liberation from invasive mechanical ventilation on day 28 from intubation.
Time Frame
28 days
Title
Time to successful liberation from invasive mechanical ventilation
Description
Time to successful liberation from invasive mechanical ventilation using competing-risks analysis.
Time Frame
28 days
Title
Time to successful liberation from invasive and noninvasive mechanical ventilation
Description
Time to successful liberation from invasive and noninvasive mechanical ventilation using competing-risks analysis.
Time Frame
28 days
Title
Intubation free days
Description
The number of days that a patient is alive and free from intubation.
Time Frame
28 days
Title
Adjusted risk ratio of successful liberation from invasive mechanical ventilation
Description
Adjusted risk ratio of successful liberation from invasive mechanical ventilation for T-piece versus inspiratory pressure augmentation group.
Time Frame
ICU discharge, up to 28 days after the initial SBT
Title
Initial SBT success
Description
Proportion of initial SBT success among patients who have started an SBT.
Time Frame
During the ICU stay, up to 28 days
Title
Extubation failure
Description
Proportion of extubation failure among patients undergoing planned extubation.
Time Frame
Five days from extubation
Title
Proportion of planned extubation
Description
Proportion of planned extubation in the ICU
Time Frame
ICU discharge, up to 28 days after the initial SBT
Title
Use of noninvasive ventilation after extubation
Description
Proportion of use of noninvasive ventilation (>24 hours) after extubation.
Time Frame
Five days from extubation
Title
ICU mortality
Description
Proportion of death in the ICU.
Time Frame
ICU discharge, up to 28 days after the initial SBT
Title
28-day mortality
Description
Probability of death in 28 days using kaplan-meier estimator.
Time Frame
28 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Admitted to the adult intensive care unit (ICU) Receiving invasive mechanical ventilation via an endotracheal tube Ready to start an SBT* *The criteria of readiness to an SBT include FiO2 ≤ 0.4, PEEP ≤ 8 cmH2O, minute ventilation ≤ 0.15 L/min/predicted body weight, inspiratory pressure or driving pressure ≤ 14 cm H2O, stable cardiovascular status and no worsening of non-pulmonary organ function. Exclusion Criteria: Age < 20 years Receiving mechanical ventilation via tracheostomy Mechanical ventilation < 12 hours Invasive ventilation started before the index hospitalization On do-not-intubate order
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sheng-Yuan Ruan, MD, PhD
Phone
886223123456
Email
syruan@ntu.edu.tw
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Daniel Fu-Chang Tsai, MD, PhD
Organizational Affiliation
National Taiwan University Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
National Taiwan University Hospital
City
Taipei
State/Province
Please Select
ZIP/Postal Code
10002
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sheng-Yuan Ruan, MD, PhD
Phone
886223123456
Email
syruan@ntu.edu.tw
Facility Name
National Taiwan University Hospital Hsin-Chu Branch
City
Hsin-Chu
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Chia-Ling Chang, MD
Facility Name
National Taiwan University Hospital Yunlin Branch
City
Yunlin
ZIP/Postal Code
63247
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yen-Fu Chen, MD
Phone
88656330002

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
The individual participant data are available from the corresponding author on reasonable request.

Learn more about this trial

Spontaneous Breathing Trial With T-piece or Inspiratory Pressure Augmentation

We'll reach out to this number within 24 hrs